Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1979-6-29
|
| pubmed:abstractText |
Chronic alcoholics with secondary depression were treated with protirelin in a double-blind, placebo-controlled study. Behavioral data, collected only during the acute alcohol withdrawal state, indicated a beneficial effect of protirelin three hours after injection, but not during subsequent days. Injections caused only mild and infrequent subjective side effects and no cardiovascular effects. Endocrine data were recorded in the acute withdrawal state and after clinical remission. Findings in the acute state suggested thyroid activation and increased central dopaminergic activity, as evidenced by elevated baseline levels of growth hormone, low baseline levels of prolactin, and blunted thyroid-stimulating hormone (TSH) response to protirelin. The first two abnormalities returned to normal levels in the remission state. A blunted TSH response was observed in both the acute and the remission states. Partial persistence of this finding suggests that TSH blunting may not be solely state-dependent. In the acute withdrawal state, TSH blunting was associated with favorable behavioral responses to protirelin.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos,
http://linkedlifedata.com/resource/pubmed/chemical/Prolactin,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin-Releasing Hormone
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0003-990X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
36
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
540-7
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:107908-Acute Disease,
pubmed-meshheading:107908-Adult,
pubmed-meshheading:107908-Alcoholism,
pubmed-meshheading:107908-Clinical Trials as Topic,
pubmed-meshheading:107908-Depression,
pubmed-meshheading:107908-Double-Blind Method,
pubmed-meshheading:107908-Drug Evaluation,
pubmed-meshheading:107908-Female,
pubmed-meshheading:107908-Growth Hormone,
pubmed-meshheading:107908-Humans,
pubmed-meshheading:107908-Male,
pubmed-meshheading:107908-Middle Aged,
pubmed-meshheading:107908-Placebos,
pubmed-meshheading:107908-Prolactin,
pubmed-meshheading:107908-Psychiatric Status Rating Scales,
pubmed-meshheading:107908-Psychological Tests,
pubmed-meshheading:107908-Remission, Spontaneous,
pubmed-meshheading:107908-Substance Withdrawal Syndrome,
pubmed-meshheading:107908-Thyrotropin,
pubmed-meshheading:107908-Thyrotropin-Releasing Hormone
|
| pubmed:year |
1979
|
| pubmed:articleTitle |
TRH (protirelin) in depressed alcoholic men. Behavioral changes and endocrine responses.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Controlled Clinical Trial
|